- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/33 - Fibroblasts
Patent holdings for IPC class A61K 35/33
Total number of patents in this class: 454
10-year publication summary
|
18
|
24
|
37
|
50
|
47
|
60
|
75
|
65
|
52
|
14
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Figene, LLC | 160 |
88 |
| Spinalcyte, LLC | 44 |
21 |
| Metcela Inc. | 17 |
12 |
| MiMedx Group, Inc. | 207 |
8 |
| Wisconsin Alumni Research Foundation | 3774 |
7 |
| Histogen, Inc. | 26 |
7 |
| The Johns Hopkins University | 5377 |
6 |
| Castle Creek Biosciences, LLC | 27 |
6 |
| Centre National de La Recherche Scientifique | 9632 |
5 |
| Elixirgen Therapeutics, Inc. | 34 |
5 |
| FUJIFILM Corporation | 27102 |
4 |
| Duke University | 2872 |
4 |
| Cedars-Sinai Medical Center | 1088 |
4 |
| Minovia Therapeutics Ltd. | 47 |
4 |
| Osiris Therapeutics, Inc. | 95 |
4 |
| Scarcell Therapeutics | 10 |
4 |
| The Regents of the University of California | 18943 |
3 |
| Allergan, Inc. | 2600 |
3 |
| Commissariat à l'énergie atomique et aux energies alternatives | 10525 |
3 |
| The General Hospital Corporation | 4517 |
3 |
| Other owners | 253 |